ArticleJournal of cancer research and clinical oncology2010

XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.

Ruchika Gangwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.